Abstract Objective We assessed national- and state-level geographic variations among patients with a history of ≥1 major atherosclerotic cardiovascular disease (ASCVD) event in: (1) the proportion of patients with retrospectively…

Highlights • HFrEF is a debilitating disease with substantial morbidity, mortality, and costs. • SGLT2i reduce adverse cardiovascular (including HF) and renal events. • SGLT2i have ushered in a new…

Highlights • 30% of young patients with FH had poor adherence to statins. • Lack of motivation was the main reason. • Higher age, more visits and years of follow-up…

Highlights • Acute cardiovascular hospitalizations in NC declined after the state of emergency order. • Declines in rates were similar in both urban and rural counties, and older individuals experienced…

Summary Introduction Familial hypercholesterolaemia (FH) is a common, heritable and preventable cause of premature coronary artery disease, with significant potential for positive impact on public health and healthcare savings. New…

Abstract Background and aims Chronic inflammation is associated with premature atherosclerotic cardiovascular disease (ASCVD). We studied the prevalence of cardiovascular risk factors (CRFs) amongst individuals with IBD who have not…

Abstract Background The Dutch cascade screening model for FH was the most successful of such programs in the world. It remains unclear whether aspects of the Dutch model (i.e. direct…

Background The U.S. Centers for Disease Control and Prevention (CDC) recognizes that older adults and individuals with certain medical conditions are at increased risk of severe COVID-19 infection. Understanding the…

Abstract Untreated hypertension may contribute to increased atherosclerotic cardiovascular disease (ASCVD) risk in South Asians (SA). We assessed HTN prevalence among untreated adults free of baseline ASCVD from the MASALA…